| human | Q5 |
| P106 | occupation | researcher | Q1650915 |
| Q40936537 | Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum |
| Q36921820 | In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger transporter (Pfnhe-1) gene in 393 isolates from Dakar, Senegal |
| Q47995034 | Molecular surveillance of drug-resistant Plasmodium vivax using pvdhfr, pvdhps and pvmdr1 markers in Nouakchott, Mauritania |
| Q33934205 | Plasmodium falciparum proteome changes in response to doxycycline treatment |
| Q36316217 | Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal |
| Q43237750 | Susceptibility of Plasmodium falciparum isolates to doxycycline is associated with pftetQ sequence polymorphisms and pftetQ and pfmdt copy numbers |
| Q41935781 | Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene |
| Q21034116 | Vivax malaria in Mauritania includes infection of a Duffy-negative individual |
Search more.